These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel in Participants With Moderate-to-Severe Acne: The Patient Journey. Baldwin H; Harper JC; Zeichner JA; Draelos ZD; Eichenfield LF; Gold M; Gold LS; Kircik LH J Drugs Dermatol; 2024 Nov; 23(11):1017-1024. PubMed ID: 39496135 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of a Fixed-Dose Clindamycin Phosphate 1.2%, Benzoyl Peroxide 3.1%, and Adapalene 0.15% Gel for Moderate-to-Severe Acne: A Randomized Phase II Study of the First Triple-Combination Drug. Stein Gold L; Baldwin H; Kircik LH; Weiss JS; Pariser DM; Callender V; Lain E; Gold M; Beer K; Draelos Z; Sadick N; Pillai R; Bhatt V; Tanghetti EA Am J Clin Dermatol; 2022 Jan; 23(1):93-104. PubMed ID: 34674160 [TBL] [Abstract][Full Text] [Related]
6. The tolerability profile of clindamycin 1%/benzoyl peroxide 5% gel vs. adapalene 0.1%/benzoyl peroxide 2.5% gel for facial acne: results of a randomized, single-blind, split-face study. Gonzalez P; Vila R; Cirigliano M J Cosmet Dermatol; 2012 Dec; 11(4):251-60. PubMed ID: 23174047 [TBL] [Abstract][Full Text] [Related]
7. Clindamycin phosphate 1.2%/benzoyl peroxide 3% fixed-dose combination gel versus topical combination therapy of adapalene 0.1% gel and clindamycin phosphate 1.2% gel in the treatment of acne vulgaris in Japanese patients: A multicenter, randomized, investigator-blind, parallel-group study. Hayashi N; Kurokawa I; Siakpere O; Endo A; Hatanaka T; Yamada M; Kawashima M J Dermatol; 2018 Aug; 45(8):951-962. PubMed ID: 29905384 [TBL] [Abstract][Full Text] [Related]
8. Adapalene 0.1%/benzoyl peroxide 2.5% gel: a review of its use in the treatment of acne vulgaris in patients aged ≥ 12 years. Keating GM Am J Clin Dermatol; 2011 Dec; 12(6):407-20. PubMed ID: 21967116 [TBL] [Abstract][Full Text] [Related]
9. Randomized, observer-blind, split-face study to compare the irritation potential of 2 topical acne formulations over a 14-day treatment period. Ting W Cutis; 2012 Aug; 90(2):91-6. PubMed ID: 22988653 [TBL] [Abstract][Full Text] [Related]
10. Tolerability and Efficacy of Clindamycin/Tretinoin versus Adapalene/Benzoyl Peroxide in the Treatment of Acne Vulgaris. Aschoff R; Möller S; Haase R; Kuske M J Drugs Dermatol; 2021 Mar; 20(3):295-301. PubMed ID: 33683070 [TBL] [Abstract][Full Text] [Related]
11. Early and Sustained Acne Lesion Reductions With Fixed-Dose Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel. Harper JC; Kircik LH; Gold M; Hebert AA; Sugarman JL; Green L; Gold LS; Baldwin H; Guenin E; DelRosso JQ J Drugs Dermatol; 2024 Mar; 23(3):125-131. PubMed ID: 38443130 [TBL] [Abstract][Full Text] [Related]
12. Two Randomized, Double-Blind, Split-Face Studies to Compare the Irritation Potential of Two Topical Acne Fixed Combinations Over a 21-Day Treatment Period. Bhatia N; Bhatt V; Martin G; Pillai R J Drugs Dermatol; 2016 Jun; 15(6):721-6. PubMed ID: 27272079 [TBL] [Abstract][Full Text] [Related]
13. Treatment of Moderate Acne Vulgaris in Fitzpatrick Skin Type V or VI: Efficacy and Tolerability of Fixed Combination Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.75% Gel. Amar L; Kircik LH J Drugs Dermatol; 2018 Oct; 17(10):1107-1112. PubMed ID: 30365592 [TBL] [Abstract][Full Text] [Related]
14. CABTREO Gupta AK; Mann A; Vincent K; Abramovits W Skinmed; 2024; 22(5):375-378. PubMed ID: 39433524 [TBL] [Abstract][Full Text] [Related]
15. Conjoint analysis: a novel, rigorous tool for determining patient preferences for topical antibiotic treatment for acne. A randomised controlled trial. Kellett N; West F; Finlay AY Br J Dermatol; 2006 Mar; 154(3):524-32. PubMed ID: 16445786 [TBL] [Abstract][Full Text] [Related]
16. Management of comedonal acne vulgaris with fixed-combination topical therapy. Gold MH; Baldwin H; Lin T J Cosmet Dermatol; 2018 Apr; 17(2):227-231. PubMed ID: 29380941 [TBL] [Abstract][Full Text] [Related]
17. Adapalene-benzoyl peroxide once-daily, fixed-dose combination gel for the treatment of acne vulgaris: a randomized, bilateral (split-face), dose-assessment study of cutaneous tolerability in healthy participants. Andres P; Pernin C; Poncet M Cutis; 2008 Mar; 81(3):278-84. PubMed ID: 18441854 [TBL] [Abstract][Full Text] [Related]
18. Skin tolerability and efficacy of combination therapy with hydrogen peroxide stabilized cream and adapalene gel in comparison with benzoyl peroxide cream and adapalene gel in common acne. A randomized, investigator-masked, controlled trial. Capizzi R; Landi F; Milani M; Amerio P Br J Dermatol; 2004 Aug; 151(2):481-4. PubMed ID: 15327558 [TBL] [Abstract][Full Text] [Related]
19. A North American study of adapalene-benzoyl peroxide combination gel in the treatment of acne. Gold LS; Tan J; Cruz-Santana A; Papp K; Poulin Y; Schlessinger J; Gidner J; Liu Y; Graeber M; Cutis; 2009 Aug; 84(2):110-6. PubMed ID: 19746769 [TBL] [Abstract][Full Text] [Related]
20. Moderate and Severe Inflammatory Acne Vulgaris Effectively Treated with Single-Agent Therapy by a New Fixed-Dose Combination Adapalene 0.3 %/Benzoyl Peroxide 2.5 % Gel: A Randomized, Double-Blind, Parallel-Group, Controlled Study. Stein Gold L; Weiss J; Rueda MJ; Liu H; Tanghetti E Am J Clin Dermatol; 2016 Jun; 17(3):293-303. PubMed ID: 26945741 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]